Pharmacological aspects of antiseizure medications: From basic mechanisms to clinical considerations of drug interactions and use of therapeutic drug monitoring
Open Access
- 1 June 2023
- journal article
- research article
- Published by Wiley in Epileptic Disorders
- Vol. 25 (4) , 454-471
Abstract
Antiseizure medications (ASMs) are the cornerstone of treatment for patients with epilepsy. Several new ASMs have recently been introduced to the market, making it possible to better tailor the treatment of epilepsy, as well as other indications (psychiatry and pain disorders). For this group of drugs there are numerous pharmacological challenges, and updated knowledge on their pharmacodynamic and pharmacokinetic properties is, therefore, crucial for an optimal treatment outcome. This review focuses on educational approaches to the following learning outcomes as described by the International League Against Epilepsy (ILAE): To demonstrate knowledge of pharmacokinetics and pharmacodynamics, drug interactions with ASMs and with concomitant medications, and appropriate monitoring of ASM serum levels (therapeutic drug monitoring, TDM). Basic principles in pharmacology, pharmacokinetic variability, and clinically relevant approaches to manage drug interactions are discussed. Furthermore, recent improvements in analytical technology and sampling are described. Future directions point to the combined implementation of TDM with genetic panels for proper diagnosis, pharmacogenetic tests where relevant, and the use of biochemical markers that will all contribute to personalized treatment. These approaches are clinically relevant for an optimal treatment outcome with ASMs in various patient groups.Keywords
This publication has 86 references indexed in Scilit:
- Antiepileptic drug treatment in pregnancy: Changes in drug disposition and their clinical implicationsEpilepsia, 2013
- Rapid assay of rufinamide in dried blood spots by a new liquid chromatography–tandem mass spectrometric methodJournal of Pharmaceutical and Biomedical Analysis, 2011
- Assessment of potential drug interactions in patients with epilepsyNeurology, 2009
- Antiepileptic drugs—best practice guidelines for therapeutic drug monitoring: A position paper by the subcommission on therapeutic drug monitoring, ILAE Commission on Therapeutic StrategiesEpilepsia, 2008
- Hyponatremia due to an Additive Effect of Carbamazepine and Thiazide DiureticsEpilepsia, 2004
- Marketed New Antiepileptic Drugs: Are They Better Than Old-Generation Agents?Therapeutic Drug Monitoring, 2002
- Is There a Role for Therapeutic Drug Monitoring of New Anticonvulsants?Clinical Pharmacokinetics, 2000
- A Multicenter Randomized Controlled Trial on the Clinical Impact of Therapeutic Drug Monitoring in Patients with Newly Diagnosed EpilepsyEpilepsia, 2000
- ABC of monitoring drug therapy. Measuring plasma drug concentrations.BMJ, 1992
- Free Level Monitoring of Antiepileptic Drugs Clinical Usefulness and Case StudiesClinical Pharmacokinetics, 1984